CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
At close: Jul 31, 2026
CERO Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.86 | 1.66 | 3.33 | 1.6 | 0.48 | 1.1 |
Cash & Short-Term Investments | 0.86 | 1.66 | 3.33 | 1.6 | 0.48 | 1.1 |
Cash Growth | -83.52% | -50.03% | 107.78% | 236.49% | -56.68% | - |
Other Current Assets | 0.72 | 1.07 | 0.39 | 0.37 | 0.23 | 0.26 |
Total Current Assets | 1.57 | 2.73 | 3.71 | 1.97 | 42.37 | 1.36 |
Net Property, Plant & Equipment | 0.63 | 0.91 | 1.99 | 3.16 | - | - |
Other Long-Term Assets | - | - | 0.5 | - | 41.67 | 178.72 |
Total Assets | 2.21 | 3.64 | 6.21 | 5.13 | 42.37 | 180.08 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 7.69 | 7.58 | 4.51 | 1.67 | 1.65 | 0.01 |
Accrued Expenses | 0.7 | 0.7 | 1.91 | 0.14 | 0.6 | 0.08 |
Short-Term Debt | - | - | - | 0.6 | 0.65 | - |
Current Portion of Leases | 0.46 | 0.7 | 0.88 | 0.77 | - | - |
Other Current Liabilities | 2.48 | 0.11 | 0.11 | 0.32 | 27.85 | 0 |
Total Current Liabilities | 11.33 | 9.09 | 7.4 | 3.51 | 30.75 | 0.1 |
Long-Term Debt | 0.14 | - | - | - | 9.15 | 9.15 |
Long-Term Leases | - | - | 0.7 | 1.58 | - | - |
Total Long-Term Liabilities | 0.14 | - | 0.7 | 1.58 | 9.15 | 9.15 |
Total Liabilities | 11.46 | 9.09 | 8.1 | 5.08 | 39.9 | 9.25 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Preferred Stock | 7.22 | 7.26 | 3.18 | 80.13 | - | - |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | 80.24 | 78.13 | 65.85 | 1.03 | - | - |
Retained Earnings | -96.72 | -90.84 | -70.92 | -43.09 | -10.76 | -7.67 |
Total Common Shareholders' Equity | -9.26 | -5.45 | -1.89 | -42.06 | -10.76 | -7.67 |
Minority Interest | - | - | - | 4.08 | 13.22 | 178.5 |
Shareholders' Equity | -9.26 | -5.45 | -1.89 | -37.98 | 2.47 | 170.83 |
Total Liabilities & Equity | 2.21 | 3.64 | 6.21 | 5.13 | 42.37 | 180.08 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.6 | 0.7 | 1.58 | 2.94 | 9.8 | 9.15 |
Net Cash (Debt) | 0.26 | 0.96 | 1.75 | -1.34 | -9.32 | -8.05 |
Net Cash Growth | -93.25% | -45.01% | - | - | - | - |
Net Cash Per Share | 0.02 | 0.23 | 60.46 | - | - | - |
Book Value | -9.26 | -5.45 | -1.89 | -42.06 | -10.76 | -7.67 |
Book Value Per Share | -0.81 | -1.29 | -65.39 | - | - | - |
Tangible Book Value | -9.26 | -5.45 | -1.89 | -42.06 | -10.76 | -7.67 |
Tangible Book Value Per Share | -0.81 | -1.29 | -65.39 | - | - | - |